Veracyte (VCYT) Down as Access for Afirma Broadened

Veracyte Inc (NASDAQ: VCYT) shares sank 1.1% to $7.50 after the company reported that it will extend access to its Afirma GEC through a deal with Quest Diagnostics. Share volume was 32,000, compared to an all-day average of 131,000